ROIV

Roivant Sciences Ltd.

Company with tickers: ROIV

CIK

1635088

CUSIP

G76279101

Shares Outstanding

719,270,385

13F Activity (30d)

235 filings 233 filers

Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.

Date	Insider	Role	Type	Shares	Price	Value	After
2026-05-22	Venker Eric	President & Immunovant CEO	Sell	200,000	$30.27	$6,054,000	1,613,063
2026-05-22	Venker Eric	President & Immunovant CEO	Convert	200,000	$3.85	$770,000	1,813,063
2026-05-22	Venker Eric	President & Immunovant CEO	Convert	200,000	—	—	4,444,834
2026-05-20	Venker Eric	President & Immunovant CEO	Tax	34,483	$32.41	$1,117,594	1,613,063
2026-05-20	Pulik Richard	CFO	Tax	18,962	$32.41	$614,558	278,549
2026-04-20	Pulik Richard	CFO	Award	60,644	—	—	297,511
2026-04-20	Humes Jennifer	Chief Accounting Officer	Award	29,173	—	—	113,364
2026-04-20	Venker Eric	President & Immunovant CEO	Sell	200,000	$29.59	$5,918,000	1,647,546
2026-04-20	Venker Eric	President & Immunovant CEO	Convert	200,000	$3.85	$770,000	1,847,546
2026-04-20	Pulik Richard	CFO	Award	84,026	—	—	84,026
2026-04-20	Venker Eric	President & Immunovant CEO	Convert	200,000	—	—	4,644,834
2026-04-20	Humes Jennifer	Chief Accounting Officer	Award	27,157	—	—	27,157
2026-04-17	Epperly Melissa B,	Director	Award	670	—	—	16,474
2026-04-17	Oren Ilan	Director	Award	896	—	—	120,324
2026-04-17	MOMTAZEE JAMES C	Director	Tax	94	$29.83	$2,804	109,405
2026-04-17	MOMTAZEE JAMES C	Director	Award	469	—	—	109,499
2026-04-17	Oren Ilan	Director	Tax	95	$29.83	$2,834	120,229
2026-04-16	Gline Matthew	Director, CEO	Sell	289,774	$29.16	$8,449,810	16,736,116
2026-04-08	Humes Jennifer	Chief Accounting Officer	Sell	13,538	$28.37	$384,073	84,191
2026-03-31	Gline Matthew	Director, CEO	Tax	304,684	$27.70	$8,439,747	17,025,890
2026-03-31	Torti Frank	President and Vant Chair	Tax	160,035	$27.70	$4,432,970	13,576,512
2026-03-31	Sukhatme Mayukh	Director, President & CIO	Tax	187,512	$27.70	$5,194,082	18,677,617
2026-03-30	Gline Matthew	Director, CEO	Tax	53,826	$26.41	$1,421,545	17,330,574
2026-03-30	Sukhatme Mayukh	Director, President & CIO	Tax	29,809	$26.41	$787,256	18,865,129
2026-03-30	Gline Matthew	Director, CEO	Convert	2,178,150	$11.50	$25,048,725	0
2026-03-30	Sukhatme Mayukh	Director, President & CIO	Convert	58,391	—	—	18,894,938
2026-03-30	Sukhatme Mayukh	Director, President & CIO	Convert	1,306,889	$11.50	$15,029,224	0
2026-03-30	Gline Matthew	Director, CEO	Convert	97,319	—	—	17,384,400
2026-03-26	Fitzgerald Meghan	Director	Convert	70,000	$8.80	$616,000	112,963
2026-03-26	Fitzgerald Meghan	Director	Convert	70,000	—	—	48,578
2026-03-26	Fitzgerald Meghan	Director	Sell	70,000	$27.45	$1,921,500	42,963
2026-03-20	Humes Jennifer	Chief Accounting Officer	Tax	14,526	$27.70	$402,370	97,729
2026-03-20	Pulik Richard	CFO	Tax	1,546	$27.70	$42,824	236,867
2026-03-17	Venker Eric	President & Immunovant CEO	Sell	200,000	$28.24	$5,648,000	1,647,546
2026-03-17	Venker Eric	President & Immunovant CEO	Convert	200,000	$3.85	$770,000	1,847,546
2026-03-17	Venker Eric	President & Immunovant CEO	Convert	200,000	—	—	4,844,834
2026-03-16	Epperly Melissa B,	Director	Sell	41,861	$28.68	$1,200,573	15,804
2026-02-23	Torti Frank	President and Vant Chair	Sell	587,390	$27.51	$16,159,099	13,736,547
2026-02-23	Torti Frank	President and Vant Chair	Convert	587,390	—	—	3,026,184
2026-02-23	Torti Frank	President and Vant Chair	Convert	587,390	$3.85	$2,261,452	14,323,937
2026-02-20	Torti Frank	President and Vant Chair	Sell	1,012,610	$27.15	$27,492,362	13,736,547
2026-02-20	Pulik Richard	CFO	Tax	1,000	$27.15	$27,150	238,413
2026-02-20	Torti Frank	President and Vant Chair	Convert	1,012,610	—	—	3,613,574
2026-02-20	Torti Frank	President and Vant Chair	Convert	1,012,610	$3.85	$3,898,549	14,749,157
2026-02-20	Venker Eric	President & Immunovant CEO	Tax	7,051	$27.15	$191,435	1,647,546
2026-02-19	Torti Frank	President and Vant Chair	Sell	1,400,000	$27.42	$38,388,000	13,736,547
2026-02-19	Torti Frank	President and Vant Chair	Convert	1,400,000	$3.85	$5,390,000	15,136,547
2026-02-19	Torti Frank	President and Vant Chair	Convert	1,400,000	—	—	4,626,184
2026-02-13	Venker Eric	President & Immunovant CEO	Convert	200,000	$3.85	$770,000	1,854,597
2026-02-13	Gold Daniel Allen	Director	Sell	150,784	$26.49	$3,994,268	15,352,329

Showing 1–50 of 1,046 transactions